Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May-Jun;14(3):241-246.
doi: 10.1016/j.dsx.2020.03.011. Epub 2020 Mar 26.

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries

Awadhesh Kumar Singh  1 , Akriti Singh  2 , Altamash Shaikh  3 , Ritu Singh  4 , Anoop Misra  5
Affiliations

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries

Awadhesh Kumar Singh et al. Diabetes Metab Syndr. 2020 May-Jun.

Abstract

Background and aims: No drugs are currently approved for Coronavirus Disease-2019 (COVID-19), although some have been tried. In view of recent studies and discussion on chloroquine and hydroxychloroquine (HCQ), we aimed to review existing literature and relevant websites regarding these drugs and COVID-19, adverse effects related to drugs, and related guidelines.

Aims and methods: We systematically searched the PubMed database up till March 21, 2020 and retrieved all the articles published on chloroquine and HCQ and COVID-19.

Results: Two small human studies have been conducted with both these drugs in COVID-19, and have shown significant improvement in some parameters in patients with COVID-19.

Conclusion: Considering minimal risk upon use, a long experience of use in other diseases, cost-effectiveness and easy availability across India, we propose that both these drugs are worthy of fast track clinical trial for treatment, and may be carefully considered for clinical use as experimental drugs. Since HCQ has been approved for treatment of diabetes in India, it should be further researched in diabetes and COVID-19, a subgroup where significant mortality has been shown.

Keywords: COVID-19; Chloroquine; Diabetes; Hydroxychloroquine.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest We hereby declare that we have no conflict of interest related to this article.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re...
    1. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. J Am Med Assoc. 2020 Feb 24 doi: 10.1001/jama.2020.2648. - DOI - PubMed
    1. Gupta R., Ghosh A., Singh A.K., Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes, Metab Syndrome Clin Res Rev. 2020 Mar 10;14(3):211–212. - PMC - PubMed
    1. Lai C.C., Liu Y.H., Wang C.Y., Wang Y.H., Hsueh S.C., Yen M.Y. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. 2020 Mar 4;(20):30040–30042. doi: 10.1016/j.jmii.2020.02.012. pii: S1684-1182, [Epub ahead of print] - DOI - PMC - PubMed
    1. LiuW, Morse J.S., Lalonde T., Xu S. Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. Chembiochem. 2020 Feb;4 doi: 10.1038/s41422-020-0282-0. - DOI - PMC - PubMed

Publication types